Docosahexaenoic Acid on Breath Holding Spells in Children

Phase 3

Recruiting

• Conditions: Breath Holding Attack
• Interventions: Drug: Placebo; Drug: DHA

• Registration Number: NCT03965988
• Lead Sponsor: Sherief Abd-Elsalam

Brief Summary

DHA on Breath Holding Spells

Detailed Description

Effect of DHA on Breath Holding Spells

Study Timeline

• Study Start: 2018-05-01
• Status Verified: 2019-05
• Study First Submitted: 2019-05-24
• Study First Submitted QC: 2019-05-24
• Last Update Submitted: 2019-05-24
• Study First Posted: 2019-05-29
• Last Update Posted: 2019-05-29
• Primary Completion: 2028-11
• Study Completion: 2028-12

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

• Children with newly diagnosed sprlls

Exclusion Criteria Other treatment as iron and piracetam

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Placebo drug	Placebo	Placebo
Docosahexaenoic Acid	DHA	Docosahexaenoic acid

Primary Outcome Measures

Name	Time	Method
Frequency of the spells	6 months	Number of attacks

Trial Locations

Locations (1)

Sherief Abd-Elsalam; 🇪🇬 Tanta, Egypt